溢多利(300381.SZ)：目前在建的还有内蒙古酶制剂三期工程及珠海总部科创园建设等项目

Core Viewpoint - The company, Yiduoli (300381.SZ), has indicated that it has increased capital expenditures due to the expansion of its R&D center and the completion of the Jinwan base, with expectations that significant new capital expenditures will not occur in the short term after the completion of ongoing projects [1] Group 1 - The company has been asked about the peak period of capital expenditures related to new production facilities [1] - Recent capital expenditures were driven by the upgrade and expansion of the R&D center and the solidification of the Jinwan base [1] - Ongoing projects include the third phase of the enzyme preparation project in Inner Mongolia and the construction of the Zhuhai headquarters innovation park [1]